CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2021

Aug 26, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2021-08-25

Reporting Person: Miller Steve (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-25	Common stock, par value $0.001 per share	M	120000	$3.12	Acquired	821724	Direct
2021-08-25	Common stock, par value $0.001 per share	S	80000	$5.558	Disposed	741724	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-25	Options to purchase common stock	$3.12	A	120000	Disposed	2021-08-28	Common Stock (120000)	Direct

Footnotes

F1: Shares were sold to cover exercise price of options and tax withholding requirements.

F2: Shares were sold in various lots from $5.51 to $5.61 per share. The listed sale price represents a weighted average price for the shares sold.

F3: Options vested in three annual tranches beginning on August 28, 2015.